| MRI-targeted or standard biopsy for prostate-cancer diagnosis V Kasivisvanathan, AS Rannikko, M Borghi, V Panebianco, LA Mynderse, ... New England Journal of Medicine 378 (19), 1767-1777, 2018 | 2716 | 2018 |
| Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT) EA Klein, IM Thompson, CM Tangen, JJ Crowley, MS Lucia, PJ Goodman, ... Jama 306 (14), 1549-1556, 2011 | 2193 | 2011 |
| Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer L Klotz, L Zhang, A Lam, R Nam, A Mamedov, A Loblaw Journal of Clinical Oncology 28 (1), 126-131, 2010 | 1375 | 2010 |
| Long-term follow-up of a large active surveillance cohort of patients with prostate cancer L Klotz, D Vesprini, P Sethukavalan, V Jethava, L Zhang, S Jain, ... J Clin oncol 33 (3), 272-277, 2015 | 1301 | 2015 |
| A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell … H Van Poppel, L Da Pozzo, W Albrecht, V Matveev, A Bono, A Borkowski, ... European urology 59 (4), 543-552, 2011 | 1279 | 2011 |
| Clinically localized prostate cancer: AUA/ASTRO/SUO guideline. Part I: risk stratification, shared decision making, and care options MG Sanda, JA Cadeddu, E Kirkby, RC Chen, T Crispino, J Fontanarosa, ... The Journal of urology 199 (3), 683-690, 2018 | 851 | 2018 |
| The efficacy and safety of degarelix: a 12‐month, comparative, randomized, open‐label, parallel‐group phase III study in patients with prostate cancer L Klotz, L Boccon‐Gibod, ND Shore, C Andreou, BE Persson, P Cantor, ... BJU international 102 (11), 1531-1538, 2008 | 794 | 2008 |
| Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy RK Nam, R Saskin, Y Lee, Y Liu, C Law, LH Klotz, DA Loblaw, ... The Journal of urology 183 (3), 963-969, 2010 | 787 | 2010 |
| Active surveillance for prostate cancer: a systematic review of the literature MA Dall’Era, PC Albertsen, C Bangma, PR Carroll, HB Carter, ... European urology 62 (6), 976-983, 2012 | 715 | 2012 |
| Image-guided prostate biopsy using magnetic resonance imaging–derived targets: a systematic review CM Moore, NL Robertson, N Arsanious, T Middleton, A Villers, L Klotz, ... European urology 63 (1), 125-140, 2013 | 669 | 2013 |
| Intermittent androgen suppression for rising PSA level after radiotherapy JM Crook, CJ O'Callaghan, G Duncan, DP Dearnaley, CS Higano, ... New England Journal of Medicine 367 (10), 895-903, 2012 | 557 | 2012 |
| A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma H Van Poppel, L Da Pozzo, W Albrecht, V Matveev, A Bono, A Borkowski, ... European urology 51 (6), 1606-1615, 2007 | 485 | 2007 |
| Active surveillance for prostate cancer: for whom? L Klotz Journal of Clinical Oncology 23 (32), 8165-8169, 2005 | 479 | 2005 |
| Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group CM Moore, V Kasivisvanathan, S Eggener, M Emberton, JJ Fütterer, ... European urology 64 (4), 544-552, 2013 | 461 | 2013 |
| Loss of Cyclin-dependent Kinase Inhibitor p27Kip1 Is a Novel Prognostic Factor in Localized Human Prostate Adenocarcinoma J Tsihlias, LR Kapusta, G DeBoer, I Morava-Protzner, I Zbieranowski, ... Cancer research 58 (3), 542-548, 1998 | 458 | 1998 |
| Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen … R Choo, L Klotz, C Danjoux, GC Morton, G DeBoer, E Szumacher, ... The Journal of urology 167 (4), 1664-1669, 2002 | 416 | 2002 |
| Cardiovascular morbidity associated with gonadotropin releasing hormone agonists and an antagonist PC Albertsen, L Klotz, B Tombal, J Grady, TK Olesen, J Nilsson European urology 65 (3), 565-573, 2014 | 389 | 2014 |
| Interferon gamma-1b compared with placebo in metastatic renal-cell carcinoma ME Gleave, M Elhilali, Y Fradet, I Davis, P Venner, F Saad, LH Klotz, ... New England journal of medicine 338 (18), 1265-1271, 1998 | 383 | 1998 |
| Magnetic resonance imaging in active surveillance of prostate cancer: a systematic review IG Schoots, N Petrides, F Giganti, LP Bokhorst, A Rannikko, L Klotz, ... European urology 67 (4), 627-636, 2015 | 378 | 2015 |
| Active surveillance for early‐stage prostate cancer: review of the current literature MA Dall'Era, MR Cooperberg, JM Chan, BJ Davies, PC Albertsen, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2008 | 371 | 2008 |
